Deletion of Podocyte STAT3 Mitigates the Entire Spectrum of HIV-1-associated Nephropathy

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2013 Jan 25

PMID 23343908

Citations 29

Authors

Leyi Gu

Yan Dai

Jin Xu

Sandeep Mallipattu

Lewis Kaufman

Paul E Klotman

John C He

Peter Y Chuang

Affiliations

Soon will be listed here.

Abstract

Objective: HIV-1 gene expression in kidney epithelial cells is thought to be responsible for the pathogenesis of HIV-1-associated nephropathy (HIVAN). Signal transducer and activator of transcription (STAT) 3 signaling is activated in podocytes of patients with HIVAN and drives the dedifferentiation and proliferation of podocytes in culture. We confirm here that deletion of podocyte STAT3 is sufficient to mitigate the glomerular as well as tubulointerstitial findings of HIVAN.

Methods: To demonstrate the functional role of podocyte STAT3 in the pathogenesis of HIVAN we compared the development of HIVAN in Tg26 HIV-transgenic mice with and without deletion of STAT3 in the podocyte.

Results: Tg26 mice with podocyte-specific STAT3 deletion developed significantly less weight loss, albuminuria, and renal function impairment compared to Tg26 mice without STAT3 deletion. Tg26 mice with podocyte STAT3 deletion also had significantly less glomerular collapse, sclerosis, epithelial cell hyperplasia, podocyte dedifferentiation, and proinflammatory STAT3 target gene expression; and tubulointerstitial changes of HIVAN, including tubular atrophy, degeneration, apoptosis, and lymphocyte infiltration, were also significantly reduced compared to Tg26 mice without STAT3 deletion.

Conclusion: Development of glomerular as well as tubulointerstitial injuries in the Tg26 HIVAN model is dependent on podocyte STAT3 expression. Inhibition of STAT3 could be a potential adjunctive therapy for the treatment of HIVAN.

Citing Articles

High glucose/ChREBP-induced Hif-1α transcriptional activation in CD4 T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response.

Zhuang S, Sun N, Qu J, Chen Q, Han C, Yin H Diabetologia. 2025; .

PMID: 39885014 DOI: 10.1007/s00125-024-06354-7.

PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy.

Yoshida T, Latt K, Rosenberg A, Santo B, Myakala K, Ishimoto Y Elife. 2024; 12.

PMID: 39207915 PMC: 11361708. DOI: 10.7554/eLife.91260.

An Update on Viral Infection-Associated Collapsing Glomerulopathy.

Fisher M, Ross M, DiFranza L, Reidy K Adv Kidney Dis Health. 2024; 31(4):317-325.

PMID: 39084757 PMC: 11296492. DOI: 10.1053/j.akdh.2023.12.007.

Central role of podocytes in mediating cellular cross talk in glomerular health and disease.

Gujarati N, Chow A, Mallipattu S Am J Physiol Renal Physiol. 2024; 326(3):F313-F325.

PMID: 38205544 PMC: 11207540. DOI: 10.1152/ajprenal.00328.2023.

Tubular-specific expression of HIV protein Vpr leads to severe tubulointerstitial damage accompanied by progressive fibrosis and cystic development.

Chen Y, Chen Y, Fu J, Sun Z, Li H, Xiao W Kidney Int. 2022; 103(3):529-543.

PMID: 36565808 PMC: 9974916. DOI: 10.1016/j.kint.2022.12.012.

References

Godel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S . Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011; 121(6):2197-209. PMC: 3104746. DOI: 10.1172/JCI44774. View

Takemoto M, Asker N, Gerhardt H, Lundkvist A, Johansson B, Saito Y . A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol. 2002; 161(3):799-805. PMC: 1867262. DOI: 10.1016/S0002-9440(10)64239-3. View

Korgaonkar S, Feng X, Ross M, Lu T, DAgati V, Iyengar R . HIV-1 upregulates VEGF in podocytes. J Am Soc Nephrol. 2008; 19(5):877-83. PMC: 2386717. DOI: 10.1681/ASN.2007050629. View

Jacoby J, Kalinowski A, Liu M, Zhang S, Gao Q, Chai G . Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci U S A. 2003; 100(22):12929-34. PMC: 240721. DOI: 10.1073/pnas.2134694100. View

Zhong J, Zuo Y, Ma J, Fogo A, Jolicoeur P, Ichikawa I . Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int. 2005; 68(3):1048-60. DOI: 10.1111/j.1523-1755.2005.00497.x. View

Kaufman L, Hayashi K, Ross M, Ross M, Klotman P . Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. J Am Soc Nephrol. 2004; 15(7):1721-30. DOI: 10.1097/01.asn.0000128975.28958.c2. View

OShea J, Plenge R . JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012; 36(4):542-50. PMC: 3499974. DOI: 10.1016/j.immuni.2012.03.014. View

Sansone P, Bromberg J . Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol. 2012; 30(9):1005-14. PMC: 3341105. DOI: 10.1200/JCO.2010.31.8907. View

DAgati V, Appel G . HIV infection and the kidney. J Am Soc Nephrol. 1997; 8(1):138-52. DOI: 10.1681/ASN.V81138. View

10.

Feng X, Lu T, Chuang P, Fang W, Ratnam K, Xiong H . Reduction of Stat3 activity attenuates HIV-induced kidney injury. J Am Soc Nephrol. 2009; 20(10):2138-46. PMC: 2754106. DOI: 10.1681/ASN.2008080879. View

11.

Page B, Ball D, Gunning P . Signal transducer and activator of transcription 3 inhibitors: a patent review. Expert Opin Ther Pat. 2010; 21(1):65-83. DOI: 10.1517/13543776.2011.539205. View

12.

Gupta S, Eustace J, Winston J, Boydstun I, Ahuja T, Rodriguez R . Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005; 40(11):1559-85. DOI: 10.1086/430257. View

13.

Peters P, Moore D, Mermin J, Brooks J, Downing R, Were W . Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 2008; 74(7):925-9. DOI: 10.1038/ki.2008.305. View

14.

Chuang P, Dai Y, Liu R, He H, Kretzler M, Jim B . Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One. 2011; 6(8):e23566. PMC: 3157434. DOI: 10.1371/journal.pone.0023566. View

15.

Wyatt C, Meliambro K, Klotman P . Recent progress in HIV-associated nephropathy. Annu Rev Med. 2011; 63:147-59. DOI: 10.1146/annurev-med-041610-134224. View

16.

Yamamoto T, Noble N, Miller D, Gold L, Hishida A, Nagase M . Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int. 1999; 55(2):579-92. DOI: 10.1046/j.1523-1755.1999.00296.x. View

17.

Bodi I, Kimmel P, Abraham A, Svetkey L, Klotman P, Kopp J . Renal TGF-beta in HIV-associated kidney diseases. Kidney Int. 1997; 51(5):1568-77. DOI: 10.1038/ki.1997.215. View

18.

Rosenstiel P, Gruosso T, Letourneau A, Chan J, LeBlanc A, Husain M . HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. Kidney Int. 2008; 74(8):1049-58. PMC: 4039560. DOI: 10.1038/ki.2008.303. View

19.

Berthier C, Zhang H, Schin M, Henger A, Nelson R, Yee B . Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes. 2008; 58(2):469-77. PMC: 2628622. DOI: 10.2337/db08-1328. View

20.

Kopp J, Klotman M, Adler S, Bruggeman L, Dickie P, Marinos N . Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A. 1992; 89(5):1577-81. PMC: 48495. DOI: 10.1073/pnas.89.5.1577. View